Does creatine cause gynaecomastia? It is a question increasingly asked by men who use this popular sports supplement and notice changes in their chest. Creatine monohydrate is one of the most researched supplements available, yet concerns persist about its potential hormonal effects. This article examines the science behind gynaecomastia, how creatine works, whether any credible biological link exists between the two, and what the current clinical evidence actually shows — helping you make an informed decision and know when to seek medical advice.

What Is Gynaecomastia and What Causes It?

Gynaecomastia is benign enlargement of glandular breast tissue in males, caused by an imbalance between oestrogen and androgen activity. Common causes include puberty, certain medications, anabolic steroids, and medical conditions such as hypogonadism or liver cirrhosis.

Gynaecomastia refers to the benign enlargement of glandular breast tissue in males. It is a relatively common condition, with prevalence estimates varying widely by age group and population; it is most frequently observed during puberty and older adulthood. It is important to distinguish true gynaecomastia — which involves actual glandular tissue growth — from pseudogynaecomastia, which is caused by excess fatty tissue in the chest area without glandular involvement.

The underlying cause of gynaecomastia is typically an imbalance between oestrogen and androgen (testosterone) activity in breast tissue. Oestrogen stimulates breast tissue growth, whilst testosterone normally counteracts this effect. When this balance is disrupted — whether through increased oestrogen levels, reduced testosterone, or heightened sensitivity of breast tissue to oestrogen — gynaecomastia can develop.

Common causes include:

• Puberty — hormonal fluctuations during adolescence are the most frequent trigger; adolescent gynaecomastia commonly resolves within 6–24 months without treatment

• Medications — including anabolic steroids, anti-androgens (e.g., spironolactone, finasteride), cimetidine, ketoconazole, some antipsychotics, and certain antihypertensives (this list is not exhaustive)

• Medical conditions — such as hypogonadism, hyperthyroidism, liver cirrhosis, or chronic kidney disease

• Recreational drug use — anabolic steroids are well-documented contributors; cannabis and alcohol have been associated with gynaecomastia in some studies, though the evidence for cannabis in particular is limited and inconclusive

• Idiopathic causes — in many cases, no clear cause is identified

According to NHS guidance, most cases of gynaecomastia are benign and self-limiting, particularly in adolescents. However, any new or persistent breast tissue change in a male should be assessed by a healthcare professional to rule out underlying pathology, including the rare possibility of male breast cancer.

How Creatine Works and Its Effects on Hormones

Creatine increases phosphocreatine availability in muscle to support ATP regeneration during high-intensity exercise; it is not a hormone or steroid and does not stimulate sex hormone production. It has no plausible biological mechanism by which it would cause gynaecomastia.

Creatine is one of the most widely used and extensively researched sports supplements available. It is a naturally occurring compound synthesised in the body from the amino acids arginine, glycine, and methionine, primarily in the liver and kidneys. It is also obtained through dietary sources, particularly red meat and fish. Supplemental creatine is most commonly taken in the form of creatine monohydrate.

The primary mechanism of action of creatine involves increasing the availability of phosphocreatine in skeletal muscle. Phosphocreatine serves as a rapid energy reserve, facilitating the regeneration of adenosine triphosphate (ATP) during short bursts of high-intensity exercise. This leads to improvements in strength, power output, and exercise capacity, which is why creatine is popular among athletes and gym-goers. Typical supplementation involves either an optional loading phase (approximately 20 g per day in divided doses for 5–7 days) followed by a maintenance dose of 3–5 g per day, or simply 3–5 g per day without a loading phase.

Creatine does not directly influence the hypothalamic-pituitary-gonadal (HPG) axis — the hormonal pathway that regulates testosterone and oestrogen production. It is not a hormone, a prohormone, or a steroid. It does not bind to androgen or oestrogen receptors, and it does not stimulate the production of sex hormones.

One area of interest has been a study suggesting that creatine supplementation may increase levels of dihydrotestosterone (DHT), a potent androgen derived from testosterone. However, this finding has not been consistently replicated. Importantly, DHT cannot be aromatised to oestrogen and is not a recognised cause of gynaecomastia — in fact, androgens generally oppose oestrogen-driven breast tissue growth. Overall, the hormonal profile of creatine supplementation does not suggest a plausible biological mechanism by which it would cause gynaecomastia.

Is There a Link Between Creatine and Gynaecomastia?

There is no established direct link between creatine supplementation and gynaecomastia. Creatine does not raise oestrogen, suppress testosterone, or act on oestrogen receptors — the key mechanisms through which gynaecomastia develops.

Based on current scientific understanding, there is no established direct link between creatine supplementation and the development of gynaecomastia. Creatine does not raise oestrogen levels, does not suppress testosterone, and does not act on oestrogen receptors in breast tissue. These are the key hormonal mechanisms through which gynaecomastia typically develops, and creatine does not appear to interfere with any of them.

The concern about creatine and gynaecomastia likely arises from a broader association between sports supplementation and hormonal side effects. Anabolic steroids and prohormone supplements — which are entirely different compounds — are well-known causes of gynaecomastia due to their conversion to oestrogen via aromatisation. Because creatine is often used in similar fitness contexts, it may be incorrectly grouped with these substances in public perception.

It is also worth noting that some commercially available creatine products — particularly those marketed as proprietary blends or "advanced formulas" — may contain additional ingredients such as herbal extracts, testosterone boosters, or other compounds. Some of these additives could theoretically influence hormone levels. Therefore, the issue may not be creatine itself, but rather undisclosed or poorly regulated co-ingredients in certain supplement products. Choosing a single-ingredient creatine monohydrate product reduces this risk.

In the UK, food supplements such as creatine are regulated under food law by the Food Standards Agency (FSA) and enforced by Trading Standards — they are not regulated as medicines by the Medicines and Healthcare products Regulatory Agency (MHRA). This means they are not subject to the same rigorous pre-market testing as licensed medicines. Consumers should choose products that carry third-party quality certification, such as Informed Sport, which tests for prohibited substances and contaminants. UK Anti-Doping (UKAD) also provides guidance on supplement contamination risks and the value of such certification schemes.

What the Current Evidence Says

No robust clinical trial or systematic review has identified gynaecomastia as an adverse effect of creatine. The ISSN 2022 position stand confirms creatine monohydrate is safe for healthy adults with no evidence of hormonal disruption.

The scientific literature on creatine is extensive, with hundreds of peer-reviewed studies examining its safety and efficacy. Importantly, no robust clinical trial or systematic review has identified gynaecomastia as an adverse effect of creatine supplementation. The International Society of Sports Nutrition (ISSN) position stand on creatine supplementation (most recently updated in 2022) consistently concludes that creatine monohydrate is safe for healthy adults when used at recommended doses, with no evidence of hormonal disruption. The International Olympic Committee (IOC) consensus statement on dietary supplements and the high-performance athlete (2018) similarly does not list gynaecomastia among creatine's known risks.

The most commonly reported side effects of creatine in the literature include:

• Water retention — creatine draws water into muscle cells, which can cause a temporary increase in body weight

• Gastrointestinal discomfort — particularly at higher loading doses

• Muscle cramping — though randomised controlled trials have not consistently demonstrated an increased risk compared with placebo

None of these effects involve breast tissue or hormonal changes.

The study that attracted most attention regarding creatine and hormones was a 2009 South African trial published in the Clinical Journal of Sport Medicine (van der Merwe et al.), which found a rise in DHT levels in rugby players taking creatine. This study had a small sample size, and its findings have not been consistently replicated in subsequent research. Furthermore, as noted above, DHT cannot be aromatised to oestrogen and is not a recognised cause of gynaecomastia.

Individuals with pre-existing chronic kidney disease or those taking nephrotoxic medicines should seek medical advice before using creatine supplements, in line with UK dietetic guidance.

In summary, the current body of evidence does not support a causal relationship between creatine use and gynaecomastia. If you believe you are experiencing an adverse reaction to any supplement, you can report this via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Other Supplements and Lifestyle Factors That May Play a Role

Anabolic androgenic steroids and prohormones are the most significant supplement-related causes of gynaecomastia. Obesity, chronic alcohol use, certain medications, and possibly phytoestrogens are also recognised contributing factors.

Whilst creatine itself is not implicated in gynaecomastia, it is important to consider the broader supplement and lifestyle context in which it is often used. Several other substances commonly taken alongside creatine in fitness settings are associated with a genuine risk of gynaecomastia.

Anabolic androgenic steroids (AAS) are among the most significant causes of supplement-related gynaecomastia, with strong supporting evidence. They elevate testosterone levels, which can be converted to oestrogen via the aromatase enzyme, leading to breast tissue stimulation. Prohormones — precursors to anabolic steroids — carry similar risks and remain available through some online retailers despite regulatory restrictions.

Other relevant factors, with varying levels of supporting evidence, include:

• Obesity — excess adipose tissue increases peripheral aromatisation of androgens to oestrogens; this association is well established

• Alcohol — chronic heavy use can impair liver function, reducing the clearance of oestrogen from the body; evidence is reasonably consistent

• Certain medications — including anti-androgens (e.g., spironolactone, finasteride), cimetidine, ketoconazole, and some antipsychotics; these have stronger evidence than many other listed factors

• Phytoestrogens — compounds found in soy-based protein supplements and certain herbal products (e.g., lavender oil, tea tree oil) that may weakly mimic oestrogen; high-quality reviews suggest that soy consumption at typical dietary intakes does not meaningfully alter male hormone levels, and the lavender/tea tree association is based largely on small case reports and in vitro data — these should be considered possible but unconfirmed contributors

• Cannabis use — associated with gynaecomastia in some observational studies, but the evidence is limited, conflicting, and of low quality; a causal link has not been established

• Proton pump inhibitors (PPIs) — occasionally reported in case reports, but evidence is limited

For individuals who develop gynaecomastia whilst using multiple supplements, it is advisable to review the full list of products being taken, including pre-workout formulas, protein powders, and herbal supplements, as these may contain active compounds not prominently labelled. A pharmacist or GP can assist in identifying potential hormonal contributors.

When to Seek Medical Advice About Breast Tissue Changes

Any male noticing breast swelling, a firm lump, nipple discharge, or skin changes should see a GP promptly to exclude serious pathology. Under NICE guideline NG12, men aged 50 or over with a unilateral firm subareolar mass should be referred urgently via the two-week-wait pathway.

Any male who notices changes in breast tissue — including swelling, tenderness, a firm lump beneath the nipple, or nipple discharge — should seek a medical assessment promptly. Whilst gynaecomastia is most commonly benign, it is essential to rule out other causes, including male breast cancer, which, although rare, accounts for approximately 1% of all breast cancer diagnoses in the UK according to Cancer Research UK.

You should contact your GP if you experience:

• A new, painless lump in the breast or chest area

• Unilateral (one-sided) breast swelling or a hard, irregular lump

• Nipple discharge, particularly if bloodstained

• Skin changes over the breast, such as dimpling or puckering

• Swollen lymph nodes in the armpit

• Breast changes accompanied by symptoms such as unexplained weight loss, fatigue, or testicular changes

Under NICE guideline NG12 (Suspected cancer: recognition and referral), men aged 50 or over who present with a unilateral, firm subareolar mass with or without nipple discharge or retraction should be referred urgently via the two-week-wait pathway to exclude breast cancer.

For confirmed gynaecomastia, investigation is guided by clinical assessment and may include blood tests such as testosterone, oestradiol, LH, FSH, prolactin, thyroid function (TSH/T4), liver function, and renal function; where a testicular tumour is suspected, serum hCG should also be measured. The specific tests ordered will depend on the clinical picture and should be determined by the assessing clinician. Management depends on the underlying cause; in many cases, addressing the precipitating factor — such as stopping a causative medication or treating an underlying condition — is sufficient.

In cases where gynaecomastia is persistent, painful, or causing significant psychological distress, referral to an endocrinologist or breast surgeon may be appropriate. Surgical options, including subcutaneous mastectomy, are available for severe or long-standing cases.

If you are currently taking creatine or any other supplement and are concerned about breast tissue changes, do not stop any prescribed medications without medical advice, and bring a full list of all supplements to your GP appointment to facilitate a thorough assessment. Suspected adverse reactions to supplements can be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Experiencing these side effects? Our pharmacists can help you navigate them →

Frequently Asked Questions